SCHEMBL4310312

SCHEMBL4310312

Cn1cccc1C(=O)Nc1ccc(OCCN2CCOCC2)cc1/C=C/c1n[nH]c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDGFRB P09619 2/20 0.43
▸ PDGFRA P16234 1/20 0.43
▸ HRH3 Q9Y5N1 1/20 0.42
▸ FLT3 P36888 5/20 0.41
▸ KIT P10721 2/20 0.41
▸ MAPK14 Q16539 5/20 0.40
▸ KDR P35968 3/20 0.40
▸ AURKA O14965 3/20 0.40
▸ CSF1R P07333 1/20 0.40
▸ HDAC1 Q13547 1/20 0.40
▸ FGFR1 P11362 1/20 0.40
▸ FLT1 P17948 1/20 0.39
▸ MAPK13 O15264 1/20 0.39
▸ MAPK12 P53778 1/20 0.39
▸ MAPK11 Q15759 1/20 0.39
▸ DDR2 Q16832 1/20 0.39
▸ DRD2 P14416 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ AURKB Q96GD4 1/20 0.38
▸ RPS6KB1 P23443 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4310316 1.00 PDGFRB (0.43) PDGFRBPDGFRAHRH3FLT3KIT
SCHEMBL4319796 0.85 AURKA (0.51) PDGFRBPDGFRAFLT3KITMAPK14
SCHEMBL4319792 0.85 AURKA (0.51) PDGFRBPDGFRAFLT3KITMAPK14
SCHEMBL4311274 0.84 HDAC1 (0.45) PDGFRBPDGFRAFLT3KITMAPK14
SCHEMBL4311280 0.84 HDAC1 (0.45) PDGFRBPDGFRAFLT3KITMAPK14
Hydrochloric Acid SCHEMBL4308932 0.83 FGFR1 (0.41) PDGFRBPDGFRAFLT3KITKDR
Hydrochloric Acid SCHEMBL4308940 0.83 FGFR1 (0.41) PDGFRBPDGFRAFLT3KITKDR
SCHEMBL4315597 0.82 MITF (0.45) PDGFRBPDGFRAFLT3KITMAPK14
SCHEMBL4315600 0.82 MITF (0.45) PDGFRBPDGFRAFLT3KITMAPK14
SCHEMBL4310263 0.80 FGFR1 (0.43) PDGFRBPDGFRAFLT3KITKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 — — US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 — — US disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 PDGFRB 167/4885PDGFRA 279/4885HRH3 500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback